Cross‐reactivity of human anti‐FVIII antibodies to porcine rFVIII: French field study to validate the modified Nijmegen method

Documenti analoghi

• Canadian clinical experience on switching from standard half‐life recombinant factor VIII (rFVIII), octocog alfa, to extended half‐life rFVIII, damoctocog alfa pegol, in persons with haemophilia A ≥ 12 years followed in a Comprehensive Hemophilia Care Program in Canada
  di: Davide Matino, et al.
  Pubblicazione: (2024)
• Does the VWF:CB Assay Help to Diagnose von Willebrand Factor Deficiency in Patients With a Bleeding Disorder of Unknown Cause?
  di: Marc Trossaërt, et al.
  Pubblicazione: (2024)
• Evaluation of 5B9 as a Calibrator or Expression of Results in Absorbance Values for the Diagnosis of Hit With a PF4/Heparin Specific Elisa
  di: Claire Pouplard, et al.
  Pubblicazione: (2025)
• 252 | IGHV AND TP53 MUTATIONAL STATUS AT DIAGNOSIS MAY HAVE IMPACT ON OUTCOME IN PATIENTS WITH SPLENIC MARGINAL ZONE LYMPHOMA
  di: E. Cappello, et al.
  Pubblicazione: (2025)
• 689 | HOW TO OPTIMIZE THE USE OF HIGH‐COST THERAPIES IN DLBCL: A COLLABORATIVE OBSERVATIONAL STUDY BY THE URUGUAYAN LYMPHOMA GROUP
  di: M. V. Irigoin, et al.
  Pubblicazione: (2025)